SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

Compound of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors CIRILLO, PIER FRANCESCO, RIETHER, DORIS, JENKINS, JAMES EDWARD, MUSHI, INNOCENT, HICKEY, EUGENE RICHARD, THOMSON, DAVID S, TAYLOR, MALCOLM, ERMANN, MONIKA, PALMER, CHRISTOPHER FRANCIS, BLUMIRE, NIGEL, CHOWDHURY, CHANDANA, BERRY, ANGELA
Format Patent
LanguageEnglish
French
German
Published 12.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compound of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Bibliography:Application Number: EP20070813203